Lack of Major Involvement of Common CYP2C Gene Polymorphisms in the Risk of Developing Cross-Hypersensitivity to NSAIDs.
Macías Y, García-Menaya JM, Martí M, Cordobés C, Jurado-Escobar R, Cornejo-García JA, Torres MJ, Blanca-López N, Canto G, Blanca M, Laguna JJ, Bartra J, Rosado A, Fernández J, García-Martín E, Agúndez JAG.
Macías Y, et al. Among authors: torres mj.
Front Pharmacol. 2021 Sep 21;12:648262. doi: 10.3389/fphar.2021.648262. eCollection 2021.
Front Pharmacol. 2021.
PMID: 34621165
Free PMC article.